Hitachi Astemo Ltd. has admitted to inspection lapses on brake and suspension systems, with the practice spanning from around 2000 through October this year.
According to the auto parts subsidiary of Japan's Hitachi Lt, it discovered that there was inappropriate conduct, including a lack of periodic tests during the manufacturing of some brake components at the Yamanashi plant between December 2020 and January 2021.
The inspection lapses also transpired during the suspension components manufacturing at its Fuhkishina plant in July 2021.
Hitachi Astemo revealed that the inspection lapses concerned 57,000 braking system parts and 10 million substandard suspension system parts.
The products in question were delivered to 16 automakers and motorcycle manufacturers, including Toyota Motor Corp, Nissan Motor Co, Honda Motor Co, and Mazda Motor Corp.
The car parts maker claimed it has so far not found any safety problems in the affected products.
Hitachi Astemo President and CEO Brice Koch apologized for employees' lack of awareness about the importance of inspections, citing poor internal communication and understaffing as causes.
Toyota and Mazda, which confirmed receiving substandard parts, said they had verified the safety of the products and dismissed the need for recalls.
Similar misconduct also occurred at other Hitachi group companies, including Hitachi Metals Ltd and the former Hitachi Chemical Co, which was bought by Showa Denko KK.
The Tokyo-based Hitachi Astemo has 145 production bases worldwide, including in the US, Europe, and China.


Goldman Sachs Private Credit Fund Sees Redemptions Ease in Q3
QNT Whales Move $10M to Exchanges After 400% Rally
Asian Stocks Rise as Bond Yields Ease Ahead of U.S. Inflation Data
Boeing Wins $20 Billion Navy F/A-XX Stealth Fighter Contract
Toyota Global Sales Fall for Seventh Month as China Demand Slumps
Gold Prices Slip as High Treasury Yields Weigh on Bullion
Lindt Slashes 2026 Sales Growth Forecast as European Demand Weakens
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
TD Cowen Starts SpaceX at Buy, Sees AI Compute Driving Growth
US Dollar Hits Two-Month High as Aussie, Pound Slide
Dollar Eases Near Two-Month High as Yen Rebounds
Bitwise Launches NEAR ETF as $562 Bull Case Fuels AI Crypto Buzz
US Stocks Slip as Treasury Yields Ease, AI Trade Rebounds
Gold Rebounds as Oil Falls and Treasury Rout Eases
Robinhood Chain Meme Coins Slide as Stock Token Locks Rise
BOJ Signals Faster Rate Hikes as Inflation Risks Grow
Nvidia China Chip Sales Report Sends Chinese Semiconductor Stocks Lower 



